How should hair loss be managed in a patient taking methotrexate (7.5–25 mg weekly) for rheumatoid arthritis or psoriasis, including the role of folic acid supplementation?

Methotrexate-Related Hair Loss Management

Folic acid supplementation (5 mg weekly, taken on non-methotrexate days) is the primary evidence-based intervention to reduce methotrexate-related hair loss and should be prescribed to all patients on methotrexate for rheumatoid arthritis or psoriasis. 1

Understanding the Problem

Hair loss occurs in approximately 29.4% of patients taking immunomodulatory doses of methotrexate, with women affected more frequently (60% of cases) 2. While the 2020 AAD-NPF guidelines acknowledge that "hair loss has been seen rarely in patients using methotrexate" with an "unknown mechanism of action," 1 real-world data suggests this side effect is more common than historically reported and represents a significant quality-of-life concern that can impact medication adherence.

Primary Management Strategy: Folic Acid Supplementation

Dosing and Administration

Folic acid supplementation is recommended with Grade A evidence to reduce methotrexate adverse effects 1. The optimal regimen based on guideline recommendations:

• Dose: 5 mg folic acid weekly (or daily dosing on non-methotrexate days)
• Timing: Given daily except on the day methotrexate is administered to avoid reducing methotrexate efficacy 1
• Alternative: Folinic acid (leucovorin) is equally effective but more expensive with no additional benefit 1

Evidence Supporting Folic Acid for Side Effect Reduction

Multiple high-quality studies demonstrate folic acid's protective effects:

• 76.9% relative risk reduction (16% absolute) in abnormal liver transaminase elevation 3
• 26% relative risk reduction (9% absolute) in GI side effects (nausea, vomiting, abdominal pain) 3
• 60.8% relative risk reduction (15.2% absolute) in patient withdrawal from methotrexate for any reason 3
• Trend toward reduction in stomatitis/mouth sores (though not statistically significant) 3

Critically, folic acid supplementation does not reduce methotrexate efficacy for treating rheumatoid arthritis or psoriasis when used at appropriate doses 3, 4, 5.

Important Caveat on Dosing

Avoid high-dose folic acid (≥5 mg daily) as recent evidence suggests this may be associated with increased cardiovascular risk in RA patients on methotrexate 6. The guideline warning that "large folic acid and folinic acid doses may reduce the efficacy of methotrexate" 1 supports using standard weekly dosing (5 mg weekly or 1 mg daily on 6 days) rather than high daily doses.

Secondary Management Strategies

Route of Administration Change

If hair loss persists despite folic acid supplementation:

• Switch from oral to subcutaneous methotrexate 1
• Subcutaneous administration may reduce GI side effects and improve bioavailability, potentially allowing for lower effective doses
• This route change is well-tolerated with no increased serious adverse events 1

Dose Adjustment

Consider dose reduction if hair loss is bothersome:

• Methotrexate dosing typically ranges from 7.5-25 mg weekly 1
• Lower doses (10 mg weekly) are slower-acting but have fewer severe adverse effects compared to 25 mg weekly 1
• Dose adjustments take at least one month to show clinical response 1

Additional Considerations from Broader Literature

While not specifically addressed in the psoriasis/RA guidelines, the broader literature suggests:

• Vitamin A supplementation may help with methotrexate-related mucocutaneous toxicity 7
• Ensure adequate baseline folate status, as poor folate status is an independent risk factor for methotrexate toxicity 8

Clinical Algorithm

1. At methotrexate initiation: Start folic acid 5 mg weekly (or 1 mg daily on 6 non-methotrexate days) 1

2. If hair loss develops despite folic acid:

   • Verify patient is taking folic acid correctly (not on methotrexate day)
   • Consider switching to subcutaneous methotrexate
   • If hair loss is severe, consider dose reduction (e.g., from 20 mg to 15 mg weekly)

3. If hair loss persists and is intolerable:

   • Reassess risk-benefit ratio
   • Consider alternative DMARDs or biologics
   • Document that hair loss is typically reversible upon methotrexate discontinuation 9

Common Pitfalls to Avoid

• Not prescribing folic acid at all: This is the most common error, particularly among dermatologists who co-prescribe folate in only 9.1% of methotrexate cases 10
• Taking folic acid on the same day as methotrexate: This may theoretically reduce methotrexate efficacy 1
• Using excessively high folic acid doses: Daily doses ≥5 mg may increase cardiovascular risk 6
• Dismissing hair loss as trivial: This side effect significantly impacts quality of life and medication adherence, particularly in women 2

Monitoring

Continue standard methotrexate monitoring (CBC, liver function tests, renal function every 3-6 months) 1. Folic acid supplementation does not eliminate the need for routine laboratory monitoring but does reduce the frequency of abnormal results 3, 4.